.svg){kind=small}
Oct-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Aliviar's performance in the Colorado market shows some interesting trends across different product categories. In the Tincture & Sublingual category, Aliviar maintained a strong presence, consistently ranking within the top 10 from July to October 2024. Although they experienced a slight dip in September, falling to 7th place, they quickly recovered to 6th position by October. This resilience is notable given the decrease in sales from July to September, before a recovery in October. However, in the Topical category, Aliviar was ranked 10th in July but did not appear in the top 30 in subsequent months, indicating a potential area for improvement or a shift in market dynamics that the brand may need to address.
The absence of Aliviar from the top 30 in the Topical category after July could suggest increased competition or a strategic shift by the brand. This contrasts with their more stable performance in Tinctures & Sublinguals, where they have shown the ability to rebound after a drop. The fluctuation in rankings and sales figures highlights the dynamic nature of the cannabis market in Colorado, where consumer preferences and competitive actions can significantly impact brand performance. Brands like Aliviar must continuously adapt to maintain and improve their market positions across different product categories.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in Colorado, Aliviar has experienced notable fluctuations in its market position over recent months. Starting in July 2024, Aliviar held a strong 5th rank, but by September, it had slipped to 7th, before slightly recovering to 6th in October. This change in rank is significant as it reflects a broader trend of declining sales, with a notable drop from August to September. In comparison, Escape Artists demonstrated remarkable resilience, climbing to the top rank in September, although it fell back to 4th in October. Meanwhile, Care Division maintained a consistently high rank, only dropping from 2nd to 5th by October, indicating a potential opportunity for Aliviar to capitalize on any further slippage by its competitors. Additionally, marQaha and SUM Microdose showed inconsistent rankings, with both brands missing from the top 20 in certain months, suggesting volatility that Aliviar could exploit to regain its earlier standing.
Notable Products
In October 2024, Aliviar's top-performing product was the CBD/THC 20:1 Calm Tincture, maintaining its first-place ranking for four consecutive months, with sales of 437 units. The CBD/THC/CBN 5:1:1 Sleep Tincture also held steady in second place throughout the same period, showing a slight increase in sales compared to September. The CBD/THC 2:1 Unscented Cream remained consistently in third place since August, although its sales dropped significantly in October. The CBD/THC 2:1 Lavender Cream, which did not rank in August and September, climbed to fourth place in October. Meanwhile, the CBD/THC 2:1 Scented Cream, which had been in third place in July, fell to fourth place by October, reflecting a downward trend in sales over the months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
